汪贻广团队发展纳米药物细胞内生物利用度定量新策略

中国药学(英文版) ›› 2021, Vol. 30 ›› Issue (5): 447-448.

汪贻广团队发展纳米药物细胞内生物利用度定量新策略

北京大学医学部药学院药剂学系

北京大学医学部药学院药剂学系

收稿日期:2021-05-20 修回日期:2021-05-20 接受日期:2021-05-20 出版日期:2021-05-31 发布日期:2021-05-31

Professor Yiguang Wang and his team developed new quantitative strategies for intracellular bioavailability of nanomedicines

Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center

Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2021-05-20 Revised:2021-05-20 Accepted:2021-05-20 Online:2021-05-31 Published:2021-05-31

摘要/Abstract

摘要： 2021年4月22日, 国际权威期刊Nature子刊《Nature Communications》在线刊登了北京大学药学院天然药物及仿生药物国家重点实验室汪贻广研究团队的最新研究成果“Quantitative imaging of intracellular nanoparticle exposure enables prediction of nanotherapeutic efficacy”。

Supporting:

北京大学医学部药学院药剂学系. 汪贻广团队发展纳米药物细胞内生物利用度定量新策略[J]. 中国药学(英文版), 2021, 30(5): 447-448.

Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University Health Science Center. Professor Yiguang Wang and his team developed new quantitative strategies for intracellular bioavailability of nanomedicines[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(5): 447-448.